Arcutis Biotherapeutics Price Target Maintained With a $18.00/Share by Needham

Arcutis Biotherapeutics的股價目標在Needham的監管下維持在18.00美元/股

道瓊斯 · 11/07 19:32 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.